Skip to Main Content

Paper Details

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
bioRxiv
0
2023
COVID-19, SARS-, SARS-CoV, SARS-CoV-2, anti-, monoclonal antibody, patients, persons, spike, spike monoclonal, target, target cell, target cells, viral infections
Author NameAffiliation
Eric S DaarLundquist Institute at Harbor-university of california los angeles Medical Center
David A WohlUniversity of North Carolina at Chapel Hill School of Medicine
Joseph J EronUniversity of North Carolina at Chapel Hill School of Medicine
Judith S CurrierDavid Geffen School of Medicine, University of California los angeles
Judith S CurrierDavid Geffen School of Medicine, University of California los angeles
  • 1 - 5

Datasets

Release 1.2